Fluzone doses (correction)
Executive Summary
Aventis Pasteur will produce an extra 2.6 mil. doses of the influenza vaccine Fluzone for distribution in the U.S. beginning in early January. "The Pink Sheet" inadvertently dropped the decimal point in reporting the number of additional doses the company will supply (1"The Pink Sheet" Oct. 25, 2004, p. 30)...
You may also be interested in...
Flu-Flop? Vaccine Shortage Becomes Presidential Campaign Issue
The emergence of the flu vaccine shortage as a Presidential campaign issue suggests that longstanding recommendations on providing incentives to manufacturers may receive serious attention in 2005
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.